133 related articles for article (PubMed ID: 28340556)
1. Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo.
Buchholz M; Majchrzak-Stiller B; Hahn S; Vangala D; Pfirrmann RW; Uhl W; Braumann C; Chromik AM
BMC Cancer; 2017 Mar; 17(1):216. PubMed ID: 28340556
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.
Chromik AM; Daigeler A; Bulut D; Flier A; May C; Harati K; Roschinsky J; Sülberg D; Ritter PR; Mittelkötter U; Hahn SA; Uhl W
J Exp Clin Cancer Res; 2010 Mar; 29(1):21. PubMed ID: 20205945
[TBL] [Abstract][Full Text] [Related]
3. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
Rodak R; Kubota H; Ishihara H; Eugster HP; Könü D; Möhler H; Yonekawa Y; Frei K
J Neurosurg; 2005 Jun; 102(6):1055-68. PubMed ID: 16028765
[TBL] [Abstract][Full Text] [Related]
4. Agarol, an ergosterol derivative from Agaricus blazei, induces caspase-independent apoptosis in human cancer cells.
Shimizu T; Kawai J; Ouchi K; Kikuchi H; Osima Y; Hidemi R
Int J Oncol; 2016 Apr; 48(4):1670-8. PubMed ID: 26893131
[TBL] [Abstract][Full Text] [Related]
5. Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines.
Hotz B; Erben U; Arndt M; Buhr HJ; Hotz HG
Int J Colorectal Dis; 2014 Nov; 29(11):1339-48. PubMed ID: 25179425
[TBL] [Abstract][Full Text] [Related]
6. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
Nici L; Monfils B; Calabresi P
Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
[TBL] [Abstract][Full Text] [Related]
7. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
8. Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors.
François RA; Maeng K; Nawab A; Kaye FJ; Hochwald SN; Zajac-Kaye M
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971297
[TBL] [Abstract][Full Text] [Related]
9. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
11. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
12. Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation.
Zou P; Xia Y; Chen T; Zhang J; Wang Z; Chen W; Chen M; Kanchana K; Yang S; Liang G
Mol Carcinog; 2016 Jun; 55(6):1073-86. PubMed ID: 26086416
[TBL] [Abstract][Full Text] [Related]
13. The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer.
Murata Y; Kokuryo T; Yokoyama Y; Yamaguchi J; Miwa T; Shibuya M; Yamamoto Y; Nagino M
Anticancer Res; 2017 Feb; 37(2):589-598. PubMed ID: 28179305
[TBL] [Abstract][Full Text] [Related]
14. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
[TBL] [Abstract][Full Text] [Related]
15. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo.
Chen YC; Shen SC; Chow JM; Ko CH; Tseng SW
Int J Oncol; 2004 Sep; 25(3):661-70. PubMed ID: 15289867
[TBL] [Abstract][Full Text] [Related]
16. Effect of Plasma-Activated Lactated Ringer's Solution on Pancreatic Cancer Cells In Vitro and In Vivo.
Sato Y; Yamada S; Takeda S; Hattori N; Nakamura K; Tanaka H; Mizuno M; Hori M; Kodera Y
Ann Surg Oncol; 2018 Jan; 25(1):299-307. PubMed ID: 29139022
[TBL] [Abstract][Full Text] [Related]
17. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.
Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE
Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928
[TBL] [Abstract][Full Text] [Related]
18. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.
Shi Y; Sahu RP; Srivastava SK
BMC Cancer; 2008 Oct; 8():294. PubMed ID: 18847491
[TBL] [Abstract][Full Text] [Related]
19. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
[TBL] [Abstract][Full Text] [Related]
20. LTP-1, a novel antimitotic agent and Stat3 inhibitor, inhibits human pancreatic carcinomas in vitro and in vivo.
Huang HL; Chao MW; Chen CC; Cheng CC; Chen MC; Lin CF; Liou JP; Teng CM; Pan SL
Sci Rep; 2016 Jun; 6():27794. PubMed ID: 27278358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
